Xtant Medical Holdings, Inc.XTNTNYSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P33
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-1.45%
Q2 20251.91%
Q1 20257.78%
Q4 2024-10.31%
Q3 2024-7.22%
Q2 20243.20%
Q1 2024-1.01%
Q4 202312.19%
Q3 202333.35%
Q2 202314.51%
Q1 202321.84%
Q4 20222.41%
Q3 20221.42%
Q2 20222.78%
Q1 2022-2.93%
Q4 202112.91%
Q3 2021-14.23%
Q2 202123.86%
Q1 2021-8.51%
Q4 20203.65%
Q3 202021.77%
Q2 2020-36.40%
Q1 2020-8.82%
Q4 20198.61%
Q3 20197.16%
Q2 2019-8.56%
Q1 20192.84%
Q4 20182.12%
Q3 2018-12.15%
Q2 20182.13%
Q1 2018-6.86%
Q4 20173.18%
Q3 2017-22.48%
Q2 20173.18%
Q1 2017-7.03%
Q4 20168.25%
Q3 20165.55%
Q2 20162.29%
Q1 2016-5.46%
Q4 201519.28%